Iron protein succinylate Disease Interactions
There are 3 disease interactions with iron protein succinylate:
Ferrous salts (applies to iron protein succinylate) hemoglobin abnormalities
Major Potential Hazard, Moderate plausibility. Applicable conditions: Blood Transfusion, Hemoglobinopathy
There is no excretory mechanism for iron. Iron will correct only hemoglobin abnormalities due to iron deficiency and should not be used to treat conditions such as thalassemia, hemosiderosis, hemochromatosis, normocytic anemia (unless iron deficiency exists), or in patients receiving blood transfusions. Clinical monitoring of erythropoietic function and ferritin levels is recommended.
- "Product Information. INFeD (iron dextran)." Schein Pharmaceuticals Inc, Florham Park, NJ.
Iron products (applies to iron protein succinylate) iron overload
Major Potential Hazard, Moderate plausibility. Applicable conditions: Thalassemia, Hemochromatosis
Iron therapy should not be used in patients with thalassemia, hemosiderosis, hemochromatosis, or in those patients receiving repeat blood transfusions due to the potential for iron overload.
Iron products (applies to iron protein succinylate) ulcers
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Peptic Ulcer, Inflammatory Bowel Disease, Achlorhydria
Iron replacement therapy should be used cautiously in patients with peptic ulcer disease, regional enteritis, or ulcerative colitis, as these patients may have poor absorption of oral iron supplements.
Iron protein succinylate drug interactions
There are 84 drug interactions with iron protein succinylate
More about iron protein succinylate
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- En Español
- 1 Review
- Drug class: iron products
Related treatment guides
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|